July 27, 2021
Anjelica Gonzalez, PhD, won a Blavatnik award for her low-cost, versatile respirator.
Photo by Michael Marsland
Even today, attention to research on women’s health remains far behind that of men, and fewer women faculty are pursuing opportunities to commercialize their research. Two organizations at Yale – Women’s Health Research at Yale (WHRY) and the Office of Cooperative Research (OCR) - are looking to change those trends, offering grants and programs specifically aimed at supporting women’s health research and supporting women faculty who wish to seek funding to bring their discoveries to a commercial light.
WHRY is one of the first centers of its kind, formed in 1998 to address the fact that women were largely excluded from clinical trials, meaning there were almost no data examining how a disease or a treatment might impact women differently than men. Launched via a grant from a private foundation, WHRY has, from its inception, offered pilot funds to
Jubilant Biosys and Yale University announce collaboration to accelerate multiple small molecule discovery programs
News provided by
Share this article
Share this article
NEW HAVEN, Conn. and BENGALURU, India, Feb. 9, 2021 /PRNewswire/ Today, Jubilant Biosys and Yale University have announced a research collaboration for multiple small molecule research programs.
Under the scope of this partnership, Jubilant Biosys will provide research services to investigators at Yale University working on novel therapeutic targets. Areas of collaboration include medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology among others.
Yale Logo
Commenting on this collaboration, Marcel Velterop, President Jubilant Biosys said
Yale is one of the top-ranked academic institutions in the US and we at Jubilant Biosys are delighted to be able to support scientific endeavours of Investigators at Yale to pursue novel target ideas for unmet medical conditions. With our New Discove